| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/03/1997 | CA2230933A1 Lantibiotic mutants and chimeras of enhanced stability and activity |
| 04/03/1997 | CA2230128A1 A modified glutamic acid decarboxylase (gad) |
| 04/03/1997 | CA2230121A1 Product and process to regulate actin polymerization |
| 04/03/1997 | CA2229263A1 Peptide derivatives, their production and use |
| 04/02/1997 | EP0765937A1 Method of producing fusion proteins |
| 04/02/1997 | EP0765936A1 Cloning of mite allergens |
| 04/02/1997 | EP0765669A1 Pharmaceutical composition for the treatment of blood coagulation disorders, process to prepare it and its use |
| 04/02/1997 | EP0765659A1 Delayed drug-releasing microspheres |
| 04/02/1997 | EP0765396A1 Locus control subregions for integration-site independent transgene expression |
| 04/02/1997 | EP0765392A1 Interleukin-5 specific recombinant antibodies |
| 04/02/1997 | EP0765344A1 Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients |
| 04/02/1997 | EP0765343A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6 |
| 04/02/1997 | EP0765342A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 04/02/1997 | EP0765340A1 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors |
| 04/02/1997 | EP0765339A1 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors |
| 04/02/1997 | EP0765338A1 Arginine mimic derivatives as enzyme inhibitors |
| 04/02/1997 | EP0765337A1 The production of hemoglobin having a delta-like globin |
| 04/02/1997 | EP0765172A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 04/02/1997 | EP0765170A1 Composition for inducing a mucosal immune response |
| 04/02/1997 | EP0765169A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 04/02/1997 | EP0765168A1 Compositions and methods for the treatment of tumors |
| 04/02/1997 | EP0765167A1 Suppression of tumor cell growth by syndecan-1 ectodomain |
| 04/02/1997 | EP0765166A1 Radiolabeled annexin-galactose conjugates |
| 04/02/1997 | EP0765165A1 Constrained peptides |
| 04/02/1997 | EP0765164A1 A PURIFIED 80 kDa PROTEIN IMPLICATED IN ABDOMINAL AORTIC ANEURYSMS, ANTIBODIES DIRECTED THERETO, AND USES THEREOF |
| 04/02/1997 | EP0765161A2 Synergistic antibiotic compositions containing a perphyrin and an antibiotic |
| 04/02/1997 | EP0765152A1 Stimulation of hair growth by peptide-copper complexes |
| 04/02/1997 | EP0765126A1 Therapeutic food composition and method to diminish blood sugar fluctuations |
| 04/02/1997 | EP0670735B1 Peripheralization of hematopoietic stem cells |
| 04/02/1997 | EP0663951A4 Chitosan matrices for encapsulated cells. |
| 04/02/1997 | EP0655089A4 Effects of actin filaments on fibrin clot structure and lysis. |
| 04/02/1997 | EP0654085B1 Monomeric and dimeric antibody-fragment fusion proteins |
| 04/02/1997 | EP0622076B1 Inhibitor for restenosis after percutaneous coronary arterioplasty |
| 04/02/1997 | EP0535048B1 Use of derivatives of human bile-salt stimulated lipase for the preparation of medicaments |
| 04/02/1997 | EP0528856B1 Processes and intermediates for synthetic antibody derivatives |
| 04/02/1997 | EP0495008B1 Vaccine conjugate for treatment of avian diseases |
| 04/02/1997 | EP0436597B1 Generation and selection of recombinant varied binding proteins |
| 04/02/1997 | CN1146782A Enzymatic antimicrobial compositions |
| 04/02/1997 | CN1146726A Block copolymers |
| 04/02/1997 | CN1146724A Heparin-binding protein for the treatment of sepsis and processes for its preparation |
| 04/02/1997 | CN1146723A Thrombolytic enzyme and method of obtaining same |
| 04/02/1997 | CN1146458A Cardiovascular active polypeptide and its synthesis and medical use |
| 04/01/1997 | US5616775 Esterifying a n-protected methionine; oxidizing; reacting with an acid anhydride then an alkali metal hydroxide |
| 04/01/1997 | US5616727 Process for purifying 1-[N2 -((S)-ethoxycarbonyl)-3-phenylpropyl)-N6 -trifluoroacetyl]-l-lysyl-l-proline (lisinopril (TFA) ethyl ester |
| 04/01/1997 | US5616720 Treating 1,6-diphenyl- or dihetero-substituted 2,5-diaminohexanol/3-/ with tetraalkoxytitanium, then amidation of reaction product and acylation yield stable viricides |
| 04/01/1997 | US5616714 Retroviral protease inhibiting compounds |
| 04/01/1997 | US5616691 Process for producing albumin preparation |
| 04/01/1997 | US5616688 Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β) |
| 04/01/1997 | US5616686 Polypeptide of a hybrid surface protein by bacteria |
| 04/01/1997 | US5616685 snRNP-A antigen and fragments thereof |
| 04/01/1997 | US5616684 Cyclic hexapeptide containing aspartic acid and derivatives, 2-thienylglycine, leucine, and tryptophan; endothelin receptor antagonist |
| 04/01/1997 | US5616620 Amino acid derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of obesity |
| 04/01/1997 | US5616612 Therapy for cancer, aids, anemia, infections |
| 04/01/1997 | US5616605 Peptide derivatives of collagenase inhibitor |
| 04/01/1997 | US5616562 Methods and compositions using substance P to promote wound healing |
| 04/01/1997 | US5616561 TGF-β antagonists as mitigators of radiation-induced tissue damage |
| 04/01/1997 | US5616560 Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
| 04/01/1997 | US5616559 Genetic engineered polypeptide viricides inhibiting virus transcription and replication |
| 04/01/1997 | US5616558 Medicaments comprising glicentin as active ingredient |
| 04/01/1997 | US5616556 Method of treating rheumatoid arthritis and osteoarthrosis using tetrahydro WS9326A |
| 04/01/1997 | US5616555 Crystalline r-h-GM-CSF and method |
| 04/01/1997 | US5616554 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 04/01/1997 | US5616491 Knockout mice |
| 04/01/1997 | US5616490 Enzymatic rna molecule which specifically cleaves messenger rna produced from gene encoding tumor necrosis factor-alpha; treating psoriasis |
| 04/01/1997 | US5616489 DNA sequence which binds transcriptional regulatory proteins activated in response to various cytokines and uses thereof |
| 04/01/1997 | US5616488 IL-5 targeted ribozymes |
| 04/01/1997 | US5616486 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 04/01/1997 | US5616483 Genomic DNA sequences encoding human BSSL/CEL |
| 04/01/1997 | US5616482 Protein fragments including an enzyme fragment a of diphtheria toxin bound together and also bound to a polypeptide ligand able to bind to selected cells; antitumor and carcinogenic agents |
| 04/01/1997 | US5616477 Fusion proteins comprising GM-CSF and antigens and their expression in yeast |
| 04/01/1997 | US5616476 Synthetic isohirudins with improved stability |
| 04/01/1997 | US5616475 Human T-cell leukemia virus transcription modulators and screening assays |
| 04/01/1997 | US5616474 K. lactis transaldolase gene promoter and use thereof |
| 04/01/1997 | US5616466 Ribozyme-mediated inhibition of bovine leukemia virus |
| 04/01/1997 | US5616348 Germicidal detergent-iodine compositions including polyvinyl pyrrolidone and compatible nonionic surfactant complexors |
| 04/01/1997 | US5616327 M-protein peptides of influenza virus as antiviral agents |
| 04/01/1997 | US5616323 Cucumis melo protein extract with antioxidant activity and process for preparing it, cosmetic or pharmaceutical composition or food composition containing such an extract |
| 04/01/1997 | US5616322 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
| 04/01/1997 | US5616321 Method of treating bacterial meningitis with anti-tumor necrosis factor antibody |
| 04/01/1997 | US5616123 Delivery of solid drug compositions |
| 04/01/1997 | US5616122 Methods and compositions for preventing secondary cataracts |
| 04/01/1997 | CA1339046C Proteins having growth hormone anabolic properties with reduced effect on carbohydrate metabolism |
| 04/01/1997 | CA1339045C Crystalline human proinsulin and process for its production |
| 04/01/1997 | CA1339044C Insulin derivatives, the use thereof, and a pharmaceutical composition containing them |
| 04/01/1997 | CA1339043C Nonapeptide and decapetide analogs of lhrh useful as lhrh antagonists |
| 04/01/1997 | CA1339033C Glycopeptide antibiotics a82846 from nocardia orientalis |
| 04/01/1997 | CA1339032C Forms of colony stimulating factor-1 |
| 03/27/1997 | WO1997011370A1 Recombinant proteins having multiple disulfide bonds and thiol-substituted conjugates thereof |
| 03/27/1997 | WO1997011366A1 Histone deacetylase as target for antiprotozoal agents |
| 03/27/1997 | WO1997011192A1 Dna encoding medicinal proteins |
| 03/27/1997 | WO1997011187A1 Subtilisin inhibitor of streptomyces venezuelae, and use of the gene sequences for expression and/or secretion of heterologous proteins in streptomyces |
| 03/27/1997 | WO1997011183A1 Streptavidin mutants |
| 03/27/1997 | WO1997011182A1 New adhesin from helicobacter pylori |
| 03/27/1997 | WO1997011180A1 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 03/27/1997 | WO1997011179A2 VARIANTS OF HUMAN RECOMBINANT INTERFERON-η (RHU-IFN-η) HAVING INCREASED HEAT-STABILITY |
| 03/27/1997 | WO1997011178A1 Human growth hormone variants |
| 03/27/1997 | WO1997011177A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | WO1997011174A1 Cyclin depenpent kinase binding compounds |
| 03/27/1997 | WO1997011173A2 Nucleic acid molecule encoding tgf receptor having modified growth inhibition, and its use |
| 03/27/1997 | WO1997011172A1 Antisense oligonucleotide chemotherapy for benign hyperplasia or cancer of the prostate |